Pages
Armed Forces Community Staff Network
Supporting DCHS in the delivery of the Armed Forces Covenant Commitments
Queens Nurse Awards 2023
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/queens-nurse-awards-2023
Plans approved for the development of Belper health services
https://dchs.nhs.uk/news/plans-approved-development-belper-health-services
Files
Data and Key Performance Indicators A15 (G320)
Data and Key Performance Indicators
Appendix 11 – Work Experience Placement Return to Practice Evaluation Form.docx
Appendix 11 – Work Placement Candidate Work Experience/Placement/Return to Practice Evaluation Form
Invite to Stage 3 - Supporting Maintaining Attendance (SAMA).docx
Invite to Stage 3 Meeting - Supporting Maintaining Attendance
0127 MUST Nutritional Screening Tool
0127 MUST Nutritional Screening Tool
Topical corticosteroid pathway for varicose eczema for community nurses (G202)
Topical corticosteroid Pathway for varicose eczema/venous stasis/stasis dermatitis for Community Nursing
L271 - Welcome to the Derbyshire Post-COVID Service
Derbyshire Community Long COVID-19 Assessment Clinic Patient information leaflet summarizes; who we are, what we do, how to be referred and what to do prior to your first appointment.
Temperature Monitoring of Medicines Storage Rooms SOP (S74)
Aim of SOP; to reduce risk to patient safety by monitoring exposure of medicines to high temperatures. DCHS accepts that the storage of medicines may exceed 25°C in exceptionally hot weather. However, all staff must follow the actions outlined in this SOP to reduce this risk.
5-Musculoskeletal Decision Making Tool Primary Care & Self Care - SHOULDER.pdf
Decision Making Tool Primary Care and Self Care - Shoulder
An introduction to leadership in DCHS
An introduction to leadership in DCHS. A useful guide for aspiring and new leaders. Equally useful to those new to the trust and new to leadership in the trust.
Control of Substances Hazardous to Health (COSHH) Statement (G281)
G281 - Control of Substances Hazardous to Health (COSHH) Statement (Section 7.1 in P69)